These emerging therapies AOD-9604 Peptide , Retatrutide, represent a significant advancement in treating type 2 diabetes and conceivably associated ailments . These drugs are classified as GLP-1 hormone stimulators, signifying these substances to replicate the natural GLP-1 peptide, stimulating insulin production and reducing hunger . Despite Retat